Corgi | $108,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
Sprout
United Kingdom
- London
- 24/02/2023
- Pre-Seed
- $1,000,000
About Sprout
From just £5,000, access one of the best performing asset classes with handpicked, high-quality venture capital funds.
With your money professionally invested by seasoned fund managers, diversify your portfolio and back the game-changing businesses of tomorrow in just a few clicks.
Why venture capital?
Venture capital has outperformed the FTSE all-share index every year since 2000.
Diversify your portfolio and access professional fund managers in a high-performing asset class uncorrelated with public markets.
HOW IT WORKS
Manage your portfolio online. Simply:
- Browse Sprout’s curated selection of high-quality VC funds
- Invest through Sprout’s platform - commit capital and transact
- Monitor portfolio performance through our regular updates
- Industry Financial Services
- Website https://www.viasprout.com/
- LinkedIn https://www.linkedin.com/company/viasprout/
Vizgen | $48,000,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Valinor(US) | $54,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
EpiBiologics | $107,000,000 | (Jan 9, 2026)
SpangleAI | $15,000,000 | (Jan 9, 2026)
Presto Phoenix, Inc. | $10,000,000 | (Jan 9, 2026)